Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

Phage display remains the most widely used antibody discovery method owing to its versatility, robustness, applicability, and ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

Integral Molecular, a leader in antibody discovery technologies, is proud to announce that the FDA has accepted their ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

Professor of Health Sciences Newman Sze and his international team have identified a specific antibody that targets ... fueling the aging process and age-related chronic diseases.

Introducing mAb technology enabled researchers to produce a single antibody to a specific antigen and replicate it in culture. In 1986, the Food and Drug Administration (FDA ... This drives the ...

to enhance its AI drug discovery capabilities. The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models. The deal also ...

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...

Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...

While deleting Lag3 significantly impedes this process, it does not completely ... The researchers gave normal mice the drug nivolumab/relatlimab, a melanoma medication that contains a Lag3 antibody, ...